Immunogen reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Amgen AMGN:US USD 37.16B 1.46B
Astellas Pharma 4503:JP JPY 82.39B 29.23B
AstraZeneca AZN:LN USD 23.68B 3.47B
Bristol Myers Squibb BMY:US USD 36.97B 141M
Eli Lilly And LLY:US USD 14.14B 548.2M
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Novartis NVS:US USD 21.24B 2.55B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K